These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

270 related items for PubMed ID: 30537561

  • 21. An analysis of factors related to the effect of sublingual immunotherapy on Japanese cedar pollen induced allergic rhinitis.
    Yonekura S, Okamoto Y, Sakurai D, Okubo K, Gotoh M, Kaneko S, Konno A.
    Allergol Int; 2018 Apr; 67(2):201-208. PubMed ID: 28760534
    [Abstract] [Full Text] [Related]

  • 22. Sublingual immunotherapy for allergic rhinitis: subjective versus objective tools to evaluate its success.
    Sakurai D, Yonekura S, Iinuma T, Sakurai T, Morimoto Y, Mita Y, Arai T, Suzuki S, Okuma Y, Kaneko S, Okamoto Y.
    Rhinology; 2016 Sep; 54(3):221-30. PubMed ID: 27107025
    [Abstract] [Full Text] [Related]

  • 23. From the genesis to the present: The evolution of sublingual immunotherapy for cedar pollinosis.
    Gotoh M, Kaminuma O, Okubo K.
    Allergol Int; 2024 Oct; 73(4):494-500. PubMed ID: 39043490
    [Abstract] [Full Text] [Related]

  • 24. A meta-analysis of sublingual allergen immunotherapy and pharmacotherapy in pollen-induced seasonal allergic rhinoconjunctivitis.
    Devillier P, Dreyfus JF, Demoly P, Calderón MA.
    BMC Med; 2014 May 01; 12():71. PubMed ID: 24885894
    [Abstract] [Full Text] [Related]

  • 25. Effects of sublingual immunotherapy with tablets or drops containing Japanese cedar pollen antigens on nasal symptoms and sleep disturbance in patients with Japanese cedar pollinosis.
    Fujii T, Kitamura Y, Kamimura S, Takeda N.
    J Med Invest; 2022 May 01; 69(1.2):97-100. PubMed ID: 35466153
    [Abstract] [Full Text] [Related]

  • 26. Recent development on the use of sublingual immunotherapy tablets for allergic rhinitis.
    Waserman S, Shah A, Avilla E.
    Ann Allergy Asthma Immunol; 2021 Aug 01; 127(2):165-175.e1. PubMed ID: 34029713
    [Abstract] [Full Text] [Related]

  • 27. Treatment Effect of the Tree Pollen SLIT-Tablet on Allergic Rhinoconjunctivitis During Oak Pollen Season.
    Nolte H, Waserman S, Ellis AK, Biedermann T, Würtzen PA.
    J Allergy Clin Immunol Pract; 2021 May 01; 9(5):1871-1878. PubMed ID: 33548518
    [Abstract] [Full Text] [Related]

  • 28. Efficacy of Japanese cedar pollen sublingual immunotherapy tablets for Japanese cypress pollinosis.
    Kurokawa T, Yonekura S, Gotoh M, Okano M, Maekawa Y, Okubo K, Okamoto Y.
    J Allergy Clin Immunol Glob; 2023 May 01; 2(2):100075. PubMed ID: 37780797
    [Abstract] [Full Text] [Related]

  • 29. A randomized controlled trial of sublingual immunotherapy for Japanese cedar pollinosis.
    Horiguchi S, Okamoto Y, Yonekura S, Okawa T, Yamamoto H, Kunii N, Sakurai D, Fujimura T, Nakazawa K, Yasueda H.
    Int Arch Allergy Immunol; 2008 May 01; 146(1):76-84. PubMed ID: 18087165
    [Abstract] [Full Text] [Related]

  • 30. Immunological effects of sublingual immunotherapy with Japanese cedar pollen extract in patients with combined Japanese cedar and Japanese cypress pollinosis.
    Kikuoka H, Kouzaki H, Matsumoto K, Arai H, Yamamoto S, Tojima I, Shimizu S, Miyashita H, Ogawa Y, Osada T, Okano M, Yuta A, Shimizu T.
    Clin Immunol; 2020 Jan 01; 210():108310. PubMed ID: 31743749
    [Abstract] [Full Text] [Related]

  • 31. [Lowered effectiveness of immunotherapy for cypress pollinosis by using Japanese cedar pollen extract].
    Horiguchi S, Okamoto Y, Yonekura S, Okawa T, Kunii N, Yamamoto H, Sakurai D, Hanazawa T.
    Arerugi; 2008 May 01; 57(5):558-61. PubMed ID: 18520178
    [Abstract] [Full Text] [Related]

  • 32. Safety and efficacy of a new regimen of short-term oral immunotherapy with Cry j 1-galactomannan conjugate for Japanese cedar pollinosis: a prospective, randomized, open-label study.
    Murakami D, Sawatsubashi M, Kikkawa S, Ejima M, Saito A, Kato A, Komune S.
    Allergol Int; 2015 Apr 01; 64(2):161-8. PubMed ID: 25838092
    [Abstract] [Full Text] [Related]

  • 33. Effect of 2 Years of Treatment With Sublingual Grass Pollen Immunotherapy on Nasal Response to Allergen Challenge at 3 Years Among Patients With Moderate to Severe Seasonal Allergic Rhinitis: The GRASS Randomized Clinical Trial.
    Scadding GW, Calderon MA, Shamji MH, Eifan AO, Penagos M, Dumitru F, Sever ML, Bahnson HT, Lawson K, Harris KM, Plough AG, Panza JL, Qin T, Lim N, Tchao NK, Togias A, Durham SR, Immune Tolerance Network GRASS Study Team.
    JAMA; 2017 Feb 14; 317(6):615-625. PubMed ID: 28196255
    [Abstract] [Full Text] [Related]

  • 34. Decreased numbers of metachromatic cells in nasal swabs in Japanese cedar pollinosis following sublingual immunotherapy.
    Otsuka K, Otsuka H, Matsune S, Okubo K.
    Immun Inflamm Dis; 2020 Sep 14; 8(3):333-341. PubMed ID: 32468704
    [Abstract] [Full Text] [Related]

  • 35. Tolerability of the SQ Tree SLIT Tablet in Adults.
    Birk AO, Andersen JS, Villesen HH, Steffensen MA, Calderon MA.
    Clin Ther; 2017 Sep 14; 39(9):1858-1867. PubMed ID: 28844318
    [Abstract] [Full Text] [Related]

  • 36. Implementation of pre-seasonal sublingual immunotherapy with a five-grass pollen tablet during optimal dosage assessment.
    Horak F, Jaeger S, Worm M, Melac M, Didier A.
    Clin Exp Allergy; 2009 Mar 14; 39(3):394-400. PubMed ID: 19134018
    [Abstract] [Full Text] [Related]

  • 37. Efficacy of sublingual immunotherapy for cedar pollinosis: A systematic review and meta-analysis.
    Yang Y, Zhou W, Chen A.
    Ann Allergy Asthma Immunol; 2016 Oct 14; 117(4):348-353. PubMed ID: 27566862
    [Abstract] [Full Text] [Related]

  • 38. Sustained 3-year efficacy of pre- and coseasonal 5-grass-pollen sublingual immunotherapy tablets in patients with grass pollen-induced rhinoconjunctivitis.
    Didier A, Worm M, Horak F, Sussman G, de Beaumont O, Le Gall M, Melac M, Malling HJ.
    J Allergy Clin Immunol; 2011 Sep 14; 128(3):559-66. PubMed ID: 21802126
    [Abstract] [Full Text] [Related]

  • 39. Magnitude of efficacy measurements in grass allergy immunotherapy trials is highly dependent on pollen exposure.
    Durham SR, Nelson HS, Nolte H, Bernstein DI, Creticos PS, Li Z, Andersen JS.
    Allergy; 2014 May 14; 69(5):617-23. PubMed ID: 24605984
    [Abstract] [Full Text] [Related]

  • 40. Intralymphatic immunotherapy for mountain cedar pollinosis: A randomized, double-blind, placebo-controlled trial.
    Thompson CP, Silvers S, Shapiro MA.
    Ann Allergy Asthma Immunol; 2020 Sep 14; 125(3):311-318.e2. PubMed ID: 32407947
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 14.